SCHEMBL3396096

SCHEMBL3396096

O=C(Cc1ccccc1)OCCCc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.66
ALDH1A1 P00352 3/20 0.61
MAPK1 P28482 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
SMN1; SMN2 Q16637 3/20 0.60
PAM P19021 1/20 0.59
NPC1 O15118 1/20 0.58
RECQL P46063 1/20 0.58
RAB9A P51151 1/20 0.58
CTDSP1 Q9GZU7 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
POLB P06746 1/20 0.56
KMT2A Q03164 1/20 0.56
APOBEC3A P31941 2/20 0.55
APOBEC3G Q9HC16 2/20 0.55
MAPT P10636 1/20 0.55
FFAR1 O14842 1/20 0.54
ALOX5 P09917 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291851 0.90 ALDH1A1 (0.68) LMNAALDH1A1MAPK1L3MBTL1TDP1
SCHEMBL4570308 0.90 ALDH1A1 (0.68) LMNAALDH1A1MAPK1L3MBTL1TDP1
SCHEMBL1434644 0.90 ALDH1A1 (0.73) LMNAALDH1A1MAPK1L3MBTL1TDP1
SCHEMBL27360871 0.89 LMNA (0.66) LMNAALDH1A1MAPK1TDP1SMN1; SMN2
SCHEMBL245747 0.89 ALDH1A1 (0.66) LMNAALDH1A1MAPK1L3MBTL1TDP1
SCHEMBL4911689 0.89 ALDH1A1 (0.66) LMNAALDH1A1MAPK1L3MBTL1TDP1
SCHEMBL7319637 0.87 TDP1 (0.75) LMNAALDH1A1MAPK1TDP1SMN1; SMN2
SCHEMBL8465673 0.87 LMNA (0.68) LMNAALDH1A1MAPK1TDP1SMN1; SMN2
Hydrocinnamyl Alcohol SCHEMBL5690147 0.86 ALOX5 (0.56) LMNAALDH1A1MAPK1L3MBTL1TDP1
SCHEMBL13398025 0.86 ALDH1A1 (0.58) LMNAALDH1A1MAPK1L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010054319-A2 PENICILLIN-G ACYLASES CODEXIS, INC. (US) 2010-05-14 WO claimed
EP-4318719-A2 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2024-02-07 EP disclosed
EP-4030524-B1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2024-02-07 EP disclosed
US-20230343990-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2023-10-26 US disclosed
US-11784342-B2 Nonaqueous electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2023-10-10 US disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
EP-4030524-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2022-07-20 EP disclosed
EP-3667803-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2020-06-17 EP disclosed
US-20200176807-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2020-06-04 US disclosed
CN-111066192-A Nonaqueous electrolyte secondary battery 三菱化学株式会社 2020-04-24 CN disclosed
CN-106999973-A System and method for discharging edible material 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
CN-106999972-A System and method for discharging fragrance 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
US-6136819-A COMPOUNDS FOR ANTIINFLAMMATORY AGENTS OR CARDIOVASCULAR DISORDERS BOEHRINGER INGELHEIM GMBH (DE) 2000-10-24 US disclosed
US-5968948-A FOR TREATMENT OF EPILEPSY, STROKE, ALZHEIMER'S DISEASE, BRAIN DISEASES OR AS ANTIINFLAMMATORY OR ANTIPROLIFERATIVE AGENTS BOERHINGER INGELHEIM GMBH (DE) 1999-10-19 US disclosed
US-5661157-A Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations BOEHRINGER INGELHEIM KG (DE) 1997-08-26 US disclosed